Chaparral Labs
back to search

protein

Apelin receptor

APLNR
protein:P35414disease:adad:direction:up

Gene

APLNR

Organism

Homo sapiens(9606)

Length

380 aa

Mass

42,660 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

Apelin receptor (APLNR) is a G protein-coupled receptor that binds the peptide hormones apelin and apelin receptor early endogenous ligand (APELA), activating intracellular signaling pathways including Gi protein and beta-arrestin cascades (UniProt: P35414). The receptor regulates cardiovascular function, fluid homeostasis, angiogenesis, and heart morphogenesis during development and in adult physiology. In an alternative capacity, it serves as a coreceptor for HIV-1 entry and has been implicated in AIDS dementia pathogenesis (UniProt: P35414).

APLNR is expressed in cardiovascular and neural tissues, with established roles in vascular development, blood pressure regulation, and cardiac contractility. The receptor also functions as a mechanoreceptor responsive to pathological stimuli, though ligand-binding can suppress maladaptive cardiac hypertrophic responses.

In Alzheimer's Disease, APLNR is significantly upregulated in post-mortem AD brain tissue relative to age-matched controls (mean log2 fold-change: 1.50, Chaparral AD proteomics). The upregulation was detected across subcellular fractions in human TMT-labeled proteomics data, suggesting potential involvement in AD-related pathophysiology, though the functional consequence remains to be determined.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↑ Up in AD

P3

not detected

P2

not detected

S2

not detected

S3

+1.500

Mean log₂FC across detected fractions: +1.4998 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

G protein-coupled receptor for peptide hormones apelin (APLN) and apelin receptor early endogenous ligand (APELA/ELA), that plays a role in the regulation of normal cardiovascular function and fluid homeostasis (PubMed:11090199, PubMed:22810587, PubMed:25639753, PubMed:28137936, PubMed:35817871, PubMed:38428423). When acting as apelin receptor, activates both G(i) protein pathway that inhibits adenylate cyclase activity, and the beta-arrestin pathway that promotes internalization of the receptor (PubMed:11090199, PubMed:25639753, PubMed:28137936, PubMed:35817871, PubMed:38428423). APLNR/APJ also functions as mechanoreceptor that is activated by pathological stimuli in a G-protein-independent fashion to induce beta-arrestin signaling, hence eliciting cardiac hypertrophy (PubMed:22810587, PubMed:38428423). However, the presence of apelin ligand blunts cardiac hypertrophic induction from APLNR/APJ on response to pathological stimuli (PubMed:22810587, PubMed:38428423). Plays a key role in early development such as gastrulation, blood vessels formation and heart morphogenesis by acting as a APELA receptor (By similarity). May promote angioblast migration toward the embryonic midline, i.e. the position of the future vessel formation, during vasculogenesis (By similarity). Promotes sinus venosus (SV)-derived endothelial cells migration into the developing heart to promote coronary blood vessel development (By similarity). Also plays a role in various processes in adults such as regulation of blood vessel formation, blood pressure, heart contractility and heart failure (PubMed:25639753, PubMed:28137936)

(Microbial infection) Alternative coreceptor with CD4 for HIV-1 infection; may be involved in the development of AIDS dementia (PubMed:11090199)

Sources

Last updated 5/8/2026, 6:31:37 AM